These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 7561649

  • 1. Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen (droloxifene) on plasma sex hormone levels in postmenopausal patients with breast cancer.
    Geisler J, Haarstad H, Gundersen S, Raabe N, Kvinnsland S, Lønning PE.
    J Endocrinol; 1995 Aug; 146(2):359-63. PubMed ID: 7561649
    [Abstract] [Full Text] [Related]

  • 2. Influence of droloxifene (3-hydroxytamoxifen), 40 mg daily, on plasma gonadotrophins, sex hormone binding globulin and estrogen levels in postmenopausal breast cancer patients.
    Geisler J, Ekse D, Hösch S, Lønning PE.
    J Steroid Biochem Mol Biol; 1995 Nov; 55(2):193-5. PubMed ID: 7495698
    [Abstract] [Full Text] [Related]

  • 3. Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients.
    Lønning PE, Johannessen DC, Lien EA, Ekse D, Fotsis T, Adlercreutz H.
    J Steroid Biochem Mol Biol; 1995 May; 52(5):491-6. PubMed ID: 7748814
    [Abstract] [Full Text] [Related]

  • 4. Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients.
    Geisler J, Engelsen BA, Berntsen H, Geisler S, Lønning PE.
    J Endocrinol; 1997 May; 153(2):307-12. PubMed ID: 9166121
    [Abstract] [Full Text] [Related]

  • 5. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients.
    Lønning PE, Helle SI, Johannessen DC, Adlercreutz H, Lien EA, Tally M, Ekse D, Fotsis T, Anker GB, Hall K.
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):23-30. PubMed ID: 7534218
    [Abstract] [Full Text] [Related]

  • 6. Plasma oestrogens in postmenopausal women with endometrial cancer.
    Nyholm HC, Nielsen AL, Lyndrup J, Dreisler A, Hagen C, Haug E.
    Br J Obstet Gynaecol; 1993 Dec; 100(12):1115-9. PubMed ID: 8297845
    [Abstract] [Full Text] [Related]

  • 7. Sex hormones in postmenopausal women with breast cancer on tamoxifen.
    Kostoglou-Athanassiou I, Ntalles K, Gogas J, Markopoulos C, Alevizou-Terzaki V, Athanassiou P, Georgiou E, Proukakis C.
    Horm Res; 1997 Dec; 47(3):116-20. PubMed ID: 9050950
    [Abstract] [Full Text] [Related]

  • 8. Re: Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
    Chobanyan NS.
    J Natl Cancer Inst; 1999 Apr 21; 91(8):724-5. PubMed ID: 10218514
    [No Abstract] [Full Text] [Related]

  • 9. Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer.
    Kyvernitakis I, Albert US, Kalder M, Winarno AS, Hars O, Hadji P.
    Climacteric; 2015 Feb 21; 18(1):63-8. PubMed ID: 24884402
    [Abstract] [Full Text] [Related]

  • 10. The minimal effective exemestane dose for endocrine activity in advanced breast cancer.
    Bajetta E, Zilembo N, Noberasco C, Martinetti A, Mariani L, Ferrari L, Buzzoni R, Greco M, Bartoli C, Spagnoli I, Danesini GM, Artale S, Paolini J.
    Eur J Cancer; 1997 Apr 21; 33(4):587-91. PubMed ID: 9274439
    [Abstract] [Full Text] [Related]

  • 11. Estrogenic effect of yam ingestion in healthy postmenopausal women.
    Wu WH, Liu LY, Chung CJ, Jou HJ, Wang TA.
    J Am Coll Nutr; 2005 Aug 21; 24(4):235-43. PubMed ID: 16093400
    [Abstract] [Full Text] [Related]

  • 12. Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years.
    Jiroutek MR, Chen MH, Johnston CC, Longcope C.
    Menopause; 1998 Aug 21; 5(2):90-4. PubMed ID: 9689202
    [Abstract] [Full Text] [Related]

  • 13. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T, Krzysiek J, Janczak-Saif A, Sztefko K, Krzyczkowska-Sendrakowska M.
    Endokrynol Pol; 2005 Aug 21; 56(6):883-90. PubMed ID: 16821206
    [Abstract] [Full Text] [Related]

  • 14. Droloxifene, a new antiestrogen. Hormonal influences in postmenopausal breast cancer patients.
    Kvinnsland S.
    Am J Clin Oncol; 1991 Aug 21; 14 Suppl 2():S46-51. PubMed ID: 1962597
    [Abstract] [Full Text] [Related]

  • 15. Case-control study of endogenous steroid hormones and endometrial cancer.
    Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR.
    J Natl Cancer Inst; 1996 Aug 21; 88(16):1127-35. PubMed ID: 8757192
    [Abstract] [Full Text] [Related]

  • 16. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom).
    Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ.
    Cancer Causes Control; 2001 Jan 21; 12(1):47-59. PubMed ID: 11227925
    [Abstract] [Full Text] [Related]

  • 17. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
    Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA.
    J Natl Cancer Inst; 2004 Jun 16; 96(12):936-45. PubMed ID: 15199113
    [Abstract] [Full Text] [Related]

  • 18. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 16; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.